No abstract available
Keywords:
HIPEC (heated intraperitoneal chemotherapy); adenocarcinoma; gastrectomy; gastric cancer; neoadjuvant chemotherapy; peritoneal metastases.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Editorial on the Research Topic Multimodal management of advanced gastric cancer
References
-
-
Garg PK, Jakhetiya A, Turaga KK, Kumar R, Brandl A, Rau B. Lack of oncological benefit from bursectomy in radical gastrectomy: A systematic review. Visc Med (2021) 37:511–20. doi: 10.1159/000517654
-
DOI
-
PMC
-
PubMed
-
-
Garg PK, Jakhetiya A, Sharma J, Ray MD, Pandey D. Lymphadenectomy in gastric cancer: Contentious issues. World J Gastrointest Surg (2016) 8:294–300. doi: 10.4240/wjgs.v8.i4.294
-
DOI
-
PMC
-
PubMed
-
-
Alberto M, Brandl A, Garg PK, Gül-Klein S, Dahlmann M, Stein U, et al. . Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview. Clin Exp Metastasis (2019) 36:1–14. doi: 10.1007/s10585-019-09955-4
-
DOI
-
PubMed
-
-
Garg PK, Jara M, Alberto M, Rau B. The role of pressurized IntraPeritoneal aerosol chemotherapy in the management of gastric cancer: A systematic review. Pleura Peritoneum (2019) 4:20180127. doi: 10.1515/pp-2018-0127
-
DOI
-
PMC
-
PubMed
-
-
Garg PK, Jain BK. New cancer drugs at the cost of bankruptcy: will the oncologist tell the patients the benefit in terms of days/weeks added to life? Oncologist (2014) 19:1291. doi: 10.1634/theoncologist.2014-0263
-
DOI
-
PMC
-
PubMed